HLA and nasopharyngeal carcinoma in chinese —A further study

This paper reports the results of 8 years of HLA typing of newly diagnosed nasopharyngeal carcinoma (NPC) patients among Chinese in Singapore, and compares the HLA profile of NPC cases with that of the normal Chinese population. Earlier results had indicated an association with A2 and BW46, but the heterogeneity of the earlier case series, which contained a proportion of long‐term survivors, obscured other aspects of the relationship. In this paper, the risk associated with A2 (relative risk = 1.5) and BW46 (relative risk = 1.9) is confirmed, showing a much higher relative risk in the presence of both antigens, and a risk is also demonstrated for B17 (relative risk = 2.1). Relative risks of less than unity are observed for All (relative risk = 0.5) and B13 (relative risk = 0.5). Data from family studies indicate the importance of the haplotype A2.BW46 in determining risk for NPC.

[1]  N. Day,et al.  Cancer incidence in Singapore 1968-1977. , 1984, IARC scientific publications.

[2]  S. Chan,et al.  LACK OF REGRESSION IN EPSTEIN-BARR VIRUS INFECTED LEUCOCYTE CULTURES OF NASOPHARYNGEAL CARCINOMA PATIENTS , 1981, The Lancet.

[3]  P. Feng,et al.  HLA and systemic lupus erythematosus in Chinese. , 1981, Human immunology.

[4]  P. Yeo,et al.  HlA haplotype sharing in affected siblings in multiple case Chinese families with thyrotoxicosis. , 2008, Tissue antigens.

[5]  M. Simons,et al.  HLA antigens in three common populations in South East Asia--Chinese, Malay and Filipino. , 2008, Tissue antigens.

[6]  S. Chan,et al.  HLA and leprosy in Chinese. , 2008, Tissue antigens.

[7]  S. Chan,et al.  CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN NASOPHARYNGEAL CARCINOMA , 1979, The Lancet.

[8]  R. Connelly,et al.  A comparison of the prognostic value of antibody‐dependent lymphocyte cytotoxicity and other ebv antibody assays in Chinese patients with nasopharyngeal carcinoma , 1979, International journal of cancer.

[9]  G. Klein,et al.  Antibody‐dependent cellular cytotoxicity against epstein‐barr virus‐associated antigens in african patients with nasopharyngeal carcinoma , 1978, International journal of cancer.

[10]  P. Yeo,et al.  HLA and thyrotoxicosis (Graves' disease) in Chinese. , 1978, Tissue antigens.

[11]  G. Gabbiani,et al.  Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients. , 1978, IARC scientific publications.

[12]  N. Day,et al.  Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2). , 1976, Journal of the National Cancer Institute.

[13]  K. Shanmugaratnam,et al.  Impaired general cell‐mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma , 1976, International journal of cancer.

[14]  N. Day,et al.  PROBABLE IDENTIFICATION OF AN HL-A SECOND-LOCUS ANTIGEN ASSOCIATED WITH A HIGH RISK OF NASOPHARYNGEAL CARCINOMA , 1975, The Lancet.

[15]  K. Utsumi,et al.  Auto-antibodies in the sera of patients with nasopharyngeal carcinoma. , 1975, IARC scientific publications.

[16]  N. Day,et al.  Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL‐A antigen profiles between patients and control groups , 1974, International journal of cancer.

[17]  V. Diehl,et al.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. , 1970, Journal of the National Cancer Institute.